What Make Adviser's Ocular Signals for VR Adviser Trades
VR Adviser recently disclosed a substantial sale of Ocular Therapeutix shares, triggering questions about what it mea...
When To Choose Etf Over Mutual Fund For Retirement Sp 500
Get guidance on choosing ETFs over mutual funds for Sp 500 retirement investing. We cover cost, liquidity, and tax considerations to help decide.
25,646 articles
Investors Growing Wary AI-Related Debt: Risks and Radar
AI champions are racing to fund data centers, but the debt that fuels this surge is drawing scrutiny. This guide expl...
How Gone From Oprah: Meghan's Sydney Retreat Costs and Real Value
Meghan Markle headlines a luxury weekend in Sydney, priced like a premium wellness retreat. This deep dive explains w...
Second Duggar Brother Facing Public Fallout and Finances
When a public figure is pulled into a legal crisis, money can follow the headlines. This article breaks down how the ...
Susan Sarandon Says Gaza and Your Financial Resilience
A high-profile stance can carry a price in Hollywood. This article explains the financial lessons from Susan Sarandon...
Charlie Puth Cancels Orlando Concert: What Fans Should Do
A last-minute cancellation can hit wallets as hard as plans. This guide breaks down how to navigate refunds, recover ...
Travis Kelce’s 1587 Prime: Legal Battle and Finances
A high-profile trademark dispute around the 1587 Prime restaurant tests more than litigation—it tests how branding, c...
Innoviva Stock Just This: Why a Fund Bought $2.5M More
A boutique fund recently boosted its Innoviva stake by $2.5 million, raising questions about the stock's modest 10% g...
Luxury Operator Draws Million: Big Fund Bet on Premium Gyms
A premium fitness brand attracts a substantial fund investment while its stock lags. This piece breaks down what it m...
Perella Weinberg Stock Lags: A Fund Bets $15 Million More
Perella Weinberg stock lags the broader market, even as a major fund just boosted its stake by about $15 million. Thi...
Cogent Biosciences Stock Soars: A Year of Gains and a $4.5M Sell
Cogent Biosciences has delivered staggering gains in a single year, yet a major fund recently trimmed its stake by mi...
Opinion: CDFI Fund Wrong—Why Deep Cuts Miss the Point
The White House is proposing a 63% cut to the CDFI Fund for FY2027, raising questions about accountability vs. capaci...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status